Search

Search Constraints

You searched for: Author/Creator Lang, Haili

Search Results

1. 414 Enhancing T cell therapy for patients with relapsed/refractory Wilms tumor. (10th December 2020)

2. 414 Enhancing T cell therapy for patients with relapsed/refractory Wilms tumor. (9th November 2020)

3. Characterization of natural killer cells expressing markers associated with maturity and cytotoxicity in children and young adults with sickle cell disease. Issue 5 (4th January 2019)

4. CTIM-33. THE REMIND TRIAL: MULTI-ANTIGEN TARGETED T CELLS FOR PEDIATRIC CNS TUMORS. (9th November 2020)

5. EPCT-15. THE REMIND TRIAL: MULTI-ANTIGEN TARGETED T CELLS FOR PEDIATRIC CNS TUMORS. (4th December 2020)

6. EPCT-24 THE REMIND TRIAL: MULTI-ANTIGEN TARGETED T CELLS FOR PEDIATRIC CNS TUMORS. (1st June 2021)

7. IMMU-19. Outcomes of Pediatric Patients with High-Risk CNS Tumors Treated with Multi-tumor associated antigen specific T cell (TAA-T) therapy: the ReMIND trial. (3rd June 2022)

10. T‐cell receptor sequencing demonstrates persistence of virus‐specific T cells after antiviral immunotherapy. (20th June 2019)